Cargando…

Aptamer-mediated survivin RNAi enables 5-fluorouracil to eliminate colorectal cancer stem cells

The development of chemoresistance and inability in elimination of cancer stem cells are among the key limitations of cancer chemotherapy. Novel molecular therapeutic strategies able to overcome such limitations are urgently needed for future effective management of cancer. In this report, we show t...

Descripción completa

Detalles Bibliográficos
Autores principales:	AlShamaileh, Hadi, Wang, Tao, Xiang, Dongxi, Yin, Wang, Tran, Phuong Ha-Lien, Barrero, Roberto A., Zhang, Pei-Zhuo, Li, Yong, Kong, Lingxue, Liu, Ke, Zhou, Shu-Feng, Hou, Yingchun, Shigdar, Sarah, Duan, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5517644/ https://www.ncbi.nlm.nih.gov/pubmed/28724889 http://dx.doi.org/10.1038/s41598-017-05859-z

Ejemplares similares

Author Correction: Aptamer-mediated survivin RNAi enables 5-fluorouracil to eliminate colorectal cancer stem cells
por: AlShamaileh, Hadi, et al.
Publicado: (2020)

EpCAM Aptamer-mediated Survivin Silencing Sensitized Cancer Stem Cells to Doxorubicin in a Breast Cancer Model
por: Wang, Tao, et al.
Publicado: (2015)

Aptamers as Theranostic Agents: Modifications, Serum Stability and Functionalisation
por: Shigdar, Sarah, et al.
Publicado: (2013)

Transforming doxorubicin into a cancer stem cell killer via EpCAM aptamer-mediated delivery
por: Xiang, Dongxi, et al.
Publicado: (2017)

Development of Cell-Specific Aptamers: Recent Advances and Insight into the Selection Procedures
por: Rahimizadeh, Kamal, et al.
Publicado: (2017)

Superior Performance of Aptamer in Tumor Penetration over Antibody: Implication of Aptamer-Based Theranostics in Solid Tumors
por: Xiang, Dongxi, et al.
Publicado: (2015)

Inhibition of Autophagy Promotes the Elimination of Liver Cancer Stem Cells by CD133 Aptamer-Targeted Delivery of Doxorubicin
por: Yin, Wang, et al.
Publicado: (2022)

Nucleic Acid Aptamer-Guided Cancer Therapeutics and Diagnostics: the Next Generation of Cancer Medicine
por: Xiang, Dongxi, et al.
Publicado: (2015)

Aptamer-guided extracellular vesicle theranostics in oncology
por: Tran, Phuong H-L, et al.
Publicado: (2020)

The inhibition of ABCB1/MDR1 or ABCG2/BCRP enables doxorubicin to eliminate liver cancer stem cells
por: Yin, Wang, et al.
Publicado: (2021)

Aptamer-Based Diagnostics and Therapeutics
por: Shigdar, Sarah
Publicado: (2019)

Epithelial cell adhesion molecule aptamer functionalized PLGA-lecithin-curcumin-PEG nanoparticles for targeted drug delivery to human colorectal adenocarcinoma cells
por: Li, Lei, et al.
Publicado: (2014)

Rapid One-Step Selection Method for Generating Nucleic Acid Aptamers: Development of a DNA Aptamer against α-Bungarotoxin
por: Lauridsen, Lasse H., et al.
Publicado: (2012)

Cancer stem cell targeted therapy: progress amid controversies
por: Wang, Tao, et al.
Publicado: (2015)

Aptamers and Glioblastoma: Their Potential Use for Imaging and Therapeutic Applications
por: Hays, Emma M., et al.
Publicado: (2017)

Radiolabelled Aptamers for Theranostic Treatment of Cancer
por: Khalid, Umair, et al.
Publicado: (2018)

Antibodies, Nanobodies, or Aptamers—Which Is Best for Deciphering the Proteomes of Non-Model Species?
por: Dhar, Poshmaal, et al.
Publicado: (2020)

Elimination of shelterin components bypasses RNAi for pericentric heterochromatin assembly
por: Tadeo, Xavier, et al.
Publicado: (2013)

Non-Invasive Delivery of Therapeutics into the Brain: The Potential of Aptamers for Targeted Delivery
por: Bukari, Bakhtiar, et al.
Publicado: (2020)

Anything You Can Do, I Can Do Better: Can Aptamers Replace Antibodies in Clinical Diagnostic Applications?
por: Bauer, Michelle, et al.
Publicado: (2019)

The Corrosion Inhibition of Montmorillonite Nanoclay for Steel in Acidic Solution
por: AlShamaileh, Ehab, et al.
Publicado: (2023)

Profiling Cancer Cells by Cell-SELEX: Use of Aptamers for Discovery of Actionable Biomarkers and Therapeutic Applications Thereof
por: Shigdar, Sarah, et al.
Publicado: (2021)

Eliminating blood oncogenic exosomes into the small intestine with aptamer-functionalized nanoparticles
por: Xie, Xiaodong, et al.
Publicado: (2019)

Facile Production Method of PbS Nanoparticles via Mechanical Milling of Galena Ore
por: Al-Saqarat, Bety S., et al.
Publicado: (2023)

Aptamer-Enabled Nanomaterials for Therapeutics, Drug Targeting and Imaging
por: Liu, Mengping, et al.
Publicado: (2022)

Aptamer-enabled uptake of small molecule ligands
por: Auwardt, Supipi Liyamali, et al.
Publicado: (2018)

Unravelling the Glioblastoma Tumour Microenvironment: Can Aptamer Targeted Delivery Become Successful in Treating Brain Cancers?
por: Giles, Breanna, et al.
Publicado: (2023)

The Diagnostic Potential of RNA Aptamers against the NS1 Protein of Dengue Virus Serotype 2
por: Thevendran, Ramesh, et al.
Publicado: (2023)

Co-targeting EGFR and survivin with a bivalent aptamer-dual siRNA chimera effectively suppresses prostate cancer
por: Liu, Hong Yan, et al.
Publicado: (2016)

Publisher Correction: Eliminating blood oncogenic exosomes into the small intestine with aptamer-functionalized nanoparticles
por: Xie, Xiaodong, et al.
Publicado: (2020)

Guanidinium-Functionalized Interpolyelectrolyte Complexes Enabling RNAi in Resistant Insect Pests
por: Parsons, Keith H., et al.
Publicado: (2018)

Targeted RNAi of BIRC5/Survivin Using Antibody-Conjugated Poly(Propylene Imine)-Based Polyplexes Inhibits Growth of PSCA-Positive Tumors
por: Jugel, Willi, et al.
Publicado: (2021)

Expression of survivin and its splice variants survivin-2B and survivin-ΔEx3 in breast cancer
por: Ryan, B, et al.
Publicado: (2005)

RNAi2013: RNAi at Oxford
por: Mulcahy, Laura A, et al.
Publicado: (2013)

Development of a CD63 Aptamer for Efficient Cancer Immunochemistry and Immunoaffinity-Based Exosome Isolation
por: Song, Zhenguo, et al.
Publicado: (2020)

Meeting Review: ESF Workshop on ‘Impact of Nucleic Acid Chemistry on Gene Function Analysis: Antisense, Aptamers, Ribozymes and RNAi’
por: Heermeier, Kathrin, et al.
Publicado: (2002)

A novel platform to enable inhaled naked RNAi medicine for lung cancer
por: Fujita, Yu, et al.
Publicado: (2013)

Endogenous spacing enables co-processing of microRNAs and efficient combinatorial RNAi
por: Amen, Alexandra M., et al.
Publicado: (2022)

Aptamer-based self-assembled nanomicelle enables efficient and targeted drug delivery
por: Chen, Ganghui, et al.
Publicado: (2023)

Bifunctional Aptamer–Doxorubicin Conjugate Crosses the Blood–Brain Barrier and Selectively Delivers Its Payload to EpCAM-Positive Tumor Cells
por: Macdonald, Joanna, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_g6ahql8mf3mufe49u1jdochfap